Belluscura (FRA:9VQ) COGS-to-Revenue : 1.15 (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Belluscura COGS-to-Revenue?

Belluscura's Cost of Goods Sold for the six months ended in Jun. 2023 was €0.39 Mil. Its Revenue for the six months ended in Jun. 2023 was €0.34 Mil.

Belluscura's COGS to Revenue for the six months ended in Jun. 2023 was 1.15.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Belluscura's Gross Margin % for the six months ended in Jun. 2023 was -15.38%.

Belluscura COGS-to-Revenue Historical Data

The historical data trend for Belluscura's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura COGS-to-Revenue Chart

Belluscura Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

1.03

0.89

1.12

0.95

Belluscura Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
COGS-to-Revenue	Get a 7-Day Free Trial				-	1.12	1.09	0.85	1.15

Belluscura COGS-to-Revenue Calculation

Belluscura's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1.256	/	1.32
	=	0.95

Belluscura's COGS to Revenue for the quarter that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.39	/	0.338
	=	1.15

Belluscura (FRA:9VQ) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Belluscura's Gross Margin % for the six months ended in Jun. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.39 / 0.338
	=	-15.38 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Belluscura COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Belluscura's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Belluscura (FRA:9VQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

BELL:UK

Address

15 Fetter Lane, Holborn, London, GBR, EC4A 1BW

Website

https://www.belluscura.com

Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines